The cumulative amounts of anti-PSMA/anti-CD3 (scFv-Fab and Fab-scFv) BsAb-armed T cells in the LNCaP tumor areas were, respectively, 10.1 and 11.7 times higher than that of OKT3-T cells (Fig. 5I). The gene discussed is FOLH1; the disease is neoplasm.